US EditionA Report Reveals the Safety and Efficacy of Dengue Vaccine a Report Prepared
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.4 Articles
4 Articles
A report produced by four scientific societies supported it and emphasized its favorable profile in clinical studies and advances in real-life research
Dengue continues to pose a significant threat to public health, especially in regions of Latin America such as Argentina, which is why four Argentine and Latin American scientific societies produced an updated document that synthesizes the available scientific evidence on immunization against this disease, especially with the tetravalent vaccine. Among its contents, the work places special emphasis on two fundamental aspects of health policy: th…
Dengue continues to represent a significant threat to public health in Latin America and, in particular, in Argentina. In this context, four Argentine and Latin American scientific societies produced an updated document that gathers the available scientific evidence on dengue immunization, with a special focus on tetravalent vaccine. The work emphasizes two central axes for health policy: the safety of the inoculator and its proven effectiveness…
The publication of a document promoted by four medical societies in Argentina and Latin America marks a new chapter in the update of the evidence on the TAK-003 tetravalent dengue vaccine. The report was prepared by the Argentine Society of Infectology (SADI), the Argentine Society of Pediatric Infectology (SADIP), the Latin American Society of Traveller Medicine (SLAMVI) and the Argentine Society of Tuberculosis and Epidemiology (SAVE), under t…
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
